Synthesis-to-Clinic®: A streamlined approach to 14C human ADME studies
Overview
We are a leading provider of 14C-enabled drug development programs, successfully conducting over 350 human ADME and other radiolabeled programs to date. Learn about Synthesis-to-Clinic®.